Valuation: Vineet Laboratories Limited

Market Cap 558M 5.85M 5.07M 4.76M 4.34M 8.15M 8.28M 55.86M 21.85M 279M 21.96M 21.48M 933M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 10.01M 8.68M 8.15M 7.43M 13.95M 14.18M 95.64M 37.41M 477M 37.59M 36.77M 1.6B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
63.66%
Yield 2024 *
-
Yield 2025 -
07-21 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
05-29 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
02-14 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02-07 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
12-17 Vineet Laboratories says rights issue price set at 30 rupees per share RE
11-27 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
11-27 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
11-24 Vineet Laboratories to consider rights issue RE
11-08 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
16/09/25 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/07/25 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
12/05/25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/11/24 Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director CI
1 day-1.39%
1 week-1.44%
Current month-3.00%
1 month+19.34%
3 months+5.40%
6 months+25.91%
Current year+4.51%
1 week 35.01
Extreme 35.01
39.94
1 month 32.35
Extreme 32.35
40.2
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
94.95
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 31/12/2020
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 09/11/2016
Director/Board Member 76 09/11/2016
Chairman 73 15/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-1.44%+13.86%-32.26% 7.85M
-0.92%+3.35%+89.07%+128.86% 1,088B
+0.47%+1.74%+51.68%+50.75% 629B
+0.83%+1.88%+26.27%+64.82% 440B
-0.88%-0.66%+47.04%+36.64% 359B
-0.37%-0.58%+28.59%+36.31% 291B
+0.05%-2.73%+5.61%+6.15% 245B
+0.40%+2.45%+46.62%+59.17% 225B
-0.42%+1.34%-6.94%-51.94% 204B
+1.67%+4.84%+15.10%+72.68% 168B
Average +0.09%+1.14%+31.69%+37.12% 364.92B
Weighted average by Cap. +0.30%+1.93%+49.09%+65.97%

Financials

2024 2025
Net sales 1.51K 15.82 13.72 12.88 11.73 22.04 22.41 151.1 59.1 754.13 59.39 58.1 2.52K 769.53 8.06 6.99 6.56 5.98 11.24 11.42 77.02 30.12 384.41 30.27 29.61 1.29K
Net income 10.27M 108K 93.34K 87.6K 79.82K 150K 152K 1.03M 402K 5.13M 404K 395K 17.17M -202M -2.12M -1.83M -1.72M -1.57M -2.95M -3M -20.21M -7.9M -101M -7.94M -7.77M -338M
Net Debt 441M 4.62M 4.01M 3.76M 3.42M 6.43M 6.54M 44.11M 17.25M 220M 17.34M 16.96M 737M 397M 4.16M 3.61M 3.39M 3.09M 5.8M 5.9M 39.78M 15.56M 199M 15.63M 15.29M 664M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
13/08/26 ₹38.44 -1.39% 83,321
12/08/26 ₹38.98 +4.14% 73,758
11/08/26 ₹37.43 +4.99% 41,991
10/08/26 ₹35.65 -3.62% 65,828
07/08/26 ₹36.99 -4.42% 73,360
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock